CDMO Profile

ProBioGen AG

ProBioGen AG Contract Manufacturing & Development (CDMO) Profile

ProBioGen AG is a renowned Contract Development and Manufacturing Organization (CDMO) and technology provider. We perform cell line engineering, process development, and GMP manufacturing of biopharmaceuticals for clients in biotech and pharma. We offer proprietary innovative technologies for optimized biopharmaceutical manufacturing and analysis. ProBioGen also provides process development services and manufacturing technologies for viral vaccines.

Our additional new building houses 1000 L single-use bioreactor capacity to keep up with the ever-increasing demand from our clients. A second 1000 L single-use bioreactor is coming soon.

With over 25 years of experience in animal cell culture, combined with innovative scientific excellence and a strong intellectual property base, we cover the entire drug development value chain end-to-end.

CDMO Services:
Biologics; Cell & Gene Therapy Sterile Vials Analytical Development; Cell Line Development; Formulation Development; ICH Stability Testing; Process Development Antibodies; Antibody-drug conjugate (ADC); Fusion Proteins; Recombinants + other Proteins; Protein Vaccines; Viral Vector Vaccines

Year Founded: 1994

Head Office: Berlin, Germany

Number of Facilities: 1-2

Facility locations: Europe

Website: Visit the ProBioGen AG website

Linkedin: Connect on Linkedin

Current Capacity: 250L/1000L

Sign up to the free weekly newsletter for all the latest news, resources and podcasts in contract manufacturing.  Register here

Experience the future of contract manufacturing

Join us at CDMO Live, 7-8 May 2025 in Rotterdam for an exclusive live event dedicated to contract manufacturing partnerships. Apply for your ticket.

INFOGRAPHIC

Download the latest infographic summarising key players in Small Molecule, Biologics and Cell & Gene Therapies.

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.